MicroRNAs relate to early worsening of renal function in patients with acute heart failure

International Journal of Cardiology

Volumn 203, Issue , 2016, Pages 564-569

  Bruno, Noemi ^a   Ter Maaten, Jozine M ^a   Ovchinnikova, Ekaterina S ^a   Vegter, Eline L ^a   Valente, Mattia A E ^a   Van Der Meer, Peter ^a   De Boer, Rudolf A ^a   Van Der Harst, Pim ^a   Schmitter, Daniela ^b   Metra, Marco ^c   O'Connor, Christopher M ^d   Ponikowski, Piotr ^e   Teerlink, John R ^f   Cotter, Gad ^g   Davison, Beth ^g   Cleland, John G ^h   Givertz, Michael M ⁱ   Bloomfield, Daniel M ^j   Dittrich, Howard C ^k   Pinto, Yigal M ^l   Van Veldhuisen, Dirk J ^a   Hillege, Hans L ^a   Berezikov, Eugene ^a   Voors, Adriaan A ^a   more..

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Momentum Research   (Switzerland)

^c UNIVERSITY OF BRESCIA   (Italy)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e WROCLAW MEDICAL UNIVERSITY   (Poland)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g Momentum Research Inc   (United States)

^h ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

ⁱ BRIGHAM AND WOMEN S HOSPITAL   (United States)

^j MERCK RESEARCH LABORATORIES   (United States)

^k UNIVERSITY OF IOWA   (United States)

^l UNIVERSITY OF AMSTERDAM   (Netherlands)

more..

Author keywords

Acute heart failure; Circulating microRNA; Worsening renal function

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MICRORNA; MICRORNA 106A 5P; MICRORNA 16 5P; MICRORNA 18A 5P; MICRORNA 199A 3P; MICRORNA 223 3P; MICRORNA 26B 5P; MICRORNA 27A 3P; MICRORNA 30E 5P; MICRORNA 423 3P; MICRORNA 423 5P; MICRORNA 652 3P; MICRORNA LET 7I 5P; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; NITRIC ACID DERIVATIVE; PLACEBO; ROLOFYLLINE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; DIURETIC AGENT; XANTHINE DERIVATIVE;

ACUTE HEART FAILURE; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; HOSPITAL ADMISSION; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); PATHOGENESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); WORSENING RENAL FUNCTION; ACUTE DISEASE; BIOSYNTHESIS; BLOOD; CLINICAL TRIAL; COMPLICATION; DISEASE COURSE; DOUBLE BLIND PROCEDURE; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; GENE EXPRESSION REGULATION; GENETICS; GLOMERULUS FILTRATION RATE; HEART FAILURE; METABOLISM; MULTICENTER STUDY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; RENAL INSUFFICIENCY; RETROSPECTIVE STUDY;

ACUTE DISEASE; AGED; BIOMARKERS; CREATININE; DISEASE PROGRESSION; DIURETICS; DOUBLE-BLIND METHOD; EARLY DIAGNOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION; GLOMERULAR FILTRATION RATE; HEART FAILURE; HUMANS; MALE; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; XANTHINES;

EID: 84952690444     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.10.217     Document Type: Article

References (33)

1. R.C. Kukreja, C. Yin, and F.N. Salloum MicroRNAs: new players in cardiac injury and protection Mol. Pharmacol. 80 4 2011 Oct 558 564
2. R. Kumarswamy, and T. Thum Non-coding RNAs in cardiac remodeling and heart failure Circ. Res. 113 2013 676 689
3. V. Oliveira-Carvalho, M.M. Fernandes da Silva, G. Veiga GuimaraËœes, F. Bacal, and E.A. Bocchi MicroRNAs: new players in heart failure Mol. Biol. Rep. 40 2013 2663 2670
4. B.A. Dickinson, H.M. Semus, R.L. Montgomery, and et al. Plasma microRNAs serve as biomarkers of therapeutic efficacy and disease progression in hypertension-induced heart failure Eur. J. Heart Fail. 15 6 2013 Jun 650 659
5. D. Schmitter, A.A. Voors, and P. van der Harst HFpEF vs. HFrEF: can microRNAs advance the diagnosis? Eur. J. Heart Fail. 17 4 2015 Apr 351 354
6. N. Nair, S. Gupta, I.X. Collier, E. Gongora, and K. Vijayaraghavan Can microRNAs emerge as biomarkers in distinguishing HFpEF versus HFrEF? Int. J. Cardiol. 175 3 2014 Aug 20 395 399
7. R. Marfella, C. Di Filippo, N. Potenza, and et al. Circulating microRNA changes in heart failure patients treated with cardiac resynchronization therapy: responders vs. non-responders Eur. J. Heart Fail. 15 11 2013 Nov 1277 1288
8. Y. Goren, M. Kushnir, B. Zafrir, S. Tabak, B.S. Lewis, and O. Amir Serum levels of microRNAs in patients with heart failure Eur. J. Heart Fail. 14 2012 147 154
9. E.S. Ovchinnikova, D. Schmitter, E.L. Vegter, and et al. Signature of circulating microRNAs in patients with acute heart failure Eur. J. Heart Fail. Sep 8 2015 10.1002/ejhf.332
10. K. Damman, M.A.E. Valente, A.A. Voors, C.M. O'Connor, D.J. Veldhuisen van, and H.L. Hillege Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis Eur. Heart J. 35 2014 455 469
11. M. Metra, G. Cotter, M. Gheorghiade, L. Dei Cas, and A.A. Voors The role of the kidney in heart failure Eur. Heart J. 33 17 2012 Sep 2135 2142
12. J.M. Testani, B.D. McCauley, J. Chen, and et al. Worsening renal function defined as an absolute increase in serum creatinine is a biased metric for the study of cardio-renal interactions Cardiology 116 3 2010 206 212
13. K. Chandrasekaran, D.S. Karolina, S. Sepramaniam, and et al. Role of microRNAs in kidney homeostasis and disease Kidney Int. 81 7 2012 617 627
14. J.M. Lorenzen, S. Batkai, and T. Thum Regulation of cardiac and renal ischemia-reperfusion injury by microRNAs Free Radic. Biol. Med. 64 2013 Sep 78 84
15. B.D. Weatherley, G. Cotter, H.C. Dittrich, and et al. Design and rationale of the PROTECT study: a placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function J. Card. Fail. 16 2010 25 35
16. A.A. Voors, H.C. Dittrich, B.M. Massie, and et al. Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function) J. Am. Coll. Cardiol. 57 2011 1899 1907
17. K. Damman, G. Navis, A.A. Voors, and et al. Worsening renal function and prognosis in heart failure: systematic review and meta-analysis J. Card. Fail. 13 8 2007 599 608
18. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(- delta delta C(T)) method Methods 25 2001 402 408
19. J.M. Lorenzen, and T. Thum Circulating and urinary microRNAs in kidney disease Clin. J. Am. Soc. Nephrol. 7 2012 1528 1533
20. J. Ho, K.H. Ng, S. Rosen, A. Dostal, R.I. Gregory, and J.A. Kreidberg Podocyte-specific loss of functional microRNAs leads to rapid glomerular and tubular injury J. Am. Soc. Nephrol. 19 11 2008 2069 2075
21. C.S. Neal, M.Z. Michael, L.K. Pimlott, T.Y. Yong, J.Y. Li, and J.M. Gleadle Circulating microRNA expression is reduced in chronic kidney disease Nephrol. Dial. Transplant. 26 2011 3794 3802
22. J.M. Lorenzen, J.T. Kielstein, C. Hafer, and et al. Circulating miR-210 predicts survival in critically ill patients with acute kidney injury Clin. J. Am. Soc. Nephrol. 6 2011 1540 1546
23. J.G. Godwin, X. Ge, K. Stephan, A. Jurisch, S.G. Tullius, and J. Iacomini Identification of a microRNA signature of renal ischemia reperfusion injury Proc. Natl. Acad. Sci. U. S. A. 107 32 Aug 10 2010 14339 14344
24. S. Rane, M. He, D. Sayed, and et al. Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes Circ. Res. 104 7 Apr 10 2009 879 886
25. A. Baumgarten, C. Bang, A. Tschirner, and et al. TWIST1 regulates the activity of ubiquitin proteasome system via the miR-199/214 cluster in human end-stage dilated cardiomyopathy Int. J. Cardiol. 168 2 Sep 30 2013 1447 1452
26. H. Azzouzi, S. Leptidis, E. Dirkx, and et al. The hypoxia-inducible microRNA cluster miR-199a ∼ 214 targets myocardial PPARδ and impairs mitochondrial fatty acid oxidation Cell Metab. 18 3 Sep 3 2013 341 354
27. J. Saikumar, D. Hoffmann, T.M. Kim, and et al. Expression, circulation, and excretion profile of microRNA-21, -155, and-18a following acute kidney injury Toxicol. Sci. 129 2 Oct 2012 256 267
28. T. Kaucsár, C. Révész, M. Godó, and et al. Activation of the miR-17 family and miR-21 during murine kidney ischemia-reperfusion injury Nucleic Acid Ther. 23 Number 5 2013 344 354
29. L.A. Goldraich, N.C. Martinelli, U. Matte, and et al. Transcoronary gradient of plasma microRNA 423-5p in heart failure: evidence of altered myocardial expression Biomarkers 19 2 Mar 2014 135 141
30. N.J. Sheerin, P.J. Newton, P.S. Macdonald, and et al. Worsening renal function in heart failure: the need for a consensus definition Int. J. Cardiol. 174 3 Jul 1 2014 484 491
31. K.L. Ellis, V.A. Cameron, R.W. Troughton, C.M. Frampton, L.J. Ellmers, and A.M. Richards Circulating microRNAs as candidate markers to distinguish heart failure in breathless patients Eur. J. Heart Fail. 15 10 Oct 2013 1138 1147
32. Q. Wei, Q.S. Mi, and Z. Dong The regulation and function of microRNAs in kidney diseases IUBMB Life 65 7 Jul 2013 602 614
33. D. Schmitter, G. Cotter, and A.A. Voors Clinical use of novel biomarkers in heart failure: towards personalized medicine Heart Fail. Rev. 19 3 May 2014 369 381